This was evidenced by several in vitro and ex vivo studies in mice as well as in humans which showed that A20 down-regulation in DCs enhances their T cell stimulatory capacity [19] and overcomes the Treg cell-mediated suppression of anti-tumor immune effector mechanisms [20]. Here, TNFAIP3 is linked to neoplasm.